Kenvue (KVUE) Stock Forecast & Price Target

$21.10 -0.09 (-0.40%)

As of 01/17/2025 03:59 PM Eastern

Kenvue - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 12 Analyst Ratings

Sell
1

Hold
7

Buy
4

Based on 12 Wall Street analysts who have issued ratings for Kenvue in the last 12 months, the stock has a consensus rating of "Hold." Out of the 12 analysts, 1 has given a sell rating, 7 have given a hold rating, and 4 have given a buy rating for KVUE.

Consensus Price Target

$23.08
9.37% Upside

According to the 12 analysts' twelve-month price targets for Kenvue, the average price target is $23.08. The highest price target for KVUE is $27.00, while the lowest price target for KVUE is $18.00. The average price target represents a forecasted upside of 9.37% from the current price of $21.11.

Get the Latest News and Ratings for KVUE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Kenvue and its competitors.

KVUE Analyst Ratings Over Time

Type	Current Forecast 1/22/24 to 1/21/25	1 Month Ago 12/23/23 to 12/22/24	3 Months Ago 10/24/23 to 10/23/24	1 Year Ago 1/22/23 to 1/22/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	3 Buy rating(s)	4 Buy rating(s)	8 Buy rating(s)
Hold	7 Hold rating(s)	8 Hold rating(s)	7 Hold rating(s)	6 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$23.08	$22.64	$22.64	$26.50
Forecasted Upside	9.37% Upside	3.98% Upside	-0.50% Downside	29.71% Upside
Consensus Rating	Hold	Hold	Hold	Moderate Buy

KVUE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

KVUE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Kenvue Stock vs. The Competition

Type	Kenvue	Consumer Staples Companies	S&P 500
Consensus Rating Score	2.25	2.49	2.52
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	9.37% Upside	46.10% Upside	12.44% Upside
News Sentiment Rating	Positive News See Recent KVUE News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
1/17/2025	Barclays 3 of 5 stars	L. Lieberman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	$23.00 ➝ $21.00	-1.20%
1/16/2025	UBS Group 4 of 5 stars	Peter Grom Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$24.00 ➝ $23.00	+8.46%
1/15/2025	Citigroup 3 of 5 stars	Filippo Falorni Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$25.00 ➝ $21.00	+0.77%
1/6/2025	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Overweight	$21.00 ➝ $26.00	+22.64%
12/12/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$25.00 ➝ $24.00	+7.96%
12/9/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Modi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Moderate Buy
10/22/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$24.00 ➝ $27.00	+18.11%
10/11/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$24.00 ➝ $25.00	+17.15%
9/24/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$27.00	+17.29%
5/8/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$20.00 ➝ $21.00	+3.09%
Get the Latest News and Ratings for KVUE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kenvue and its competitors with MarketBeat's FREE daily newsletter.
4/11/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Underperform	$18.00	-11.02%
4/3/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Andersen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Market Perform
3/1/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy ➝ Neutral	$20.00	+5.24%
9/7/2023	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$28.00	+25.06%
9/6/2023	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold
7/25/2023	Edward Jones Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy
5/30/2023	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$28.00	+6.46%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 05:55 AM ET.

Should I Buy Kenvue Stock? KVUE Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, January 19, 2025. Please send any questions or comments about these Kenvue pros and cons to contact@marketbeat.com.

Kenvue
Bull Case

Here are some ways that investors could benefit from investing in Kenvue Inc.:

Kenvue Inc. has recently received a "buy" rating from Jefferies Financial Group with a price objective of $27.00, indicating strong potential for price appreciation.
The company reported earnings per share (EPS) of $0.28 for the latest quarter, surpassing analysts' expectations of $0.27, which reflects strong operational performance.
With a current stock price of $21.07, Kenvue Inc. is trading below some analysts' target prices, suggesting potential upside for investors.
Kenvue Inc. has a solid market capitalization of approximately $40.40 billion, indicating a stable and established presence in the consumer health sector.
The company offers a quarterly dividend of $0.205 per share, translating to an annualized yield of 3.89%, providing income to investors in addition to potential capital gains.

Kenvue
Bear Case

Investors should be bearish about investing in Kenvue Inc. for these reasons:

Kenvue Inc. has a relatively high price-to-earnings (P/E) ratio of 38.31, which may indicate that the stock is overvalued compared to its earnings.
The company experienced a slight decline in revenue, down 0.4% compared to the same quarter last year, which could signal potential challenges in maintaining growth.
Analysts have issued a mix of ratings, with one sell rating and several hold ratings, suggesting uncertainty about the stock's future performance.
The company's payout ratio is notably high at 149.09%, indicating that it is paying out more in dividends than it is earning, which could be unsustainable in the long run.
Recent downgrades from Deutsche Bank and Barclays, with target prices lowered, may reflect a bearish sentiment among some analysts regarding Kenvue Inc.'s future prospects.

KVUE Forecast - Frequently Asked Questions

: According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Kenvue is $23.08, with a high forecast of $27.00 and a low forecast of $18.00.
: 12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Kenvue in the last year. There is currently 1 sell rating, 7 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" KVUE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KVUE, but not buy additional shares or sell existing shares.
: According to analysts, Kenvue's stock has a predicted upside of 9.37% based on their 12-month stock forecasts.
: Over the previous 90 days, Kenvue's stock had 3 upgrades and 1 downgrade by analysts.
: Kenvue has been rated by research analysts at Barclays, Citigroup, Deutsche Bank Aktiengesellschaft, Piper Sandler, Royal Bank of Canada, and UBS Group in the past 90 days.
: Analysts like Kenvue less than other "consumer staples" companies. The consensus rating score for Kenvue is 2.25 while the average consensus rating score for "consumer staples" companies is 2.49. Learn more on how KVUE compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

This page (NYSE:KVUE) was last updated on 1/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kenvue (KVUE) Stock Forecast & Price Target